Literature DB >> 22176838

Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys.

J Damman1, M R Daha, H G Leuvenink, H van Goor, J L Hillebrands, M C van Dijk, B G Hepkema, H Snieder, J van den Born, M H de Borst, S J Bakker, G J Navis, R J Ploeg, M A Seelen.   

Abstract

Local renal complement activation by the donor kidney plays an important role in the pathogenesis of renal injury inherent to kidney transplantation. Contradictory results were reported about the protective effects of the donor C3F allotype on renal allograft outcome. We investigated the influence of the donor C3F allotype on renal transplant outcome, taking all different donor types into account. C3 allotypes of 1265 donor-recipient pairs were determined and divided into four genotypic groups according to the C3F allotype of the donor and the recipient. The four genotypic groups were analyzed for association with primary nonfunction (PNF), delayed graft function, acute rejection, death-censored graft survival and patient survival. Considering all donor types, multivariable analysis found no association of the donor C3F allotype with renal allograft outcome. Also, for living and deceased brain-dead donors, no association with allograft outcome was found. Post hoc subgroup analysis within deceased cardiac dead (DCD) donors revealed an independent protective association of donor C3F allotype with PNF. This study shows that the donor C3F allotype is not associated with renal allograft outcome after kidney transplantation. Subgroup analysis within DCD donors revealed an independent protective association of the donor C3F allotype with PNF, which is preliminary and warrants further validation. © copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22176838     DOI: 10.1111/j.1600-6143.2011.03880.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  18 in total

Review 1.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.

Authors:  Qi Cheng; Kunal Patel; Biao Lei; Lindsay Rucker; D Patterson Allen; Peng Zhu; Chentha Vasu; Paulo N Martins; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Transplant       Date:  2018-04-10       Impact factor: 8.086

Review 3.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

4.  Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts.

Authors:  Carl Atkinson; Bernhard Floerchinger; Fei Qiao; Sarah Casey; Tucker Williamson; Ellen Moseley; Serban Stoica; Martin Goddard; Xupeng Ge; Stefan G Tullius; Stephen Tomlinson
Journal:  Circulation       Date:  2013-02-26       Impact factor: 29.690

5.  Genetic Polymorphisms in the Host and COVID-19 Infection.

Authors:  Joris R Delanghe; Marc L De Buyzere; Marijn M Speeckaert
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Design and Implementation of the International Genetics and Translational Research in Transplantation Network.

Authors: 
Journal:  Transplantation       Date:  2015-11       Impact factor: 4.939

7.  Donor and recipient genetic variants in NLRP3 associate with early acute rejection following kidney transplantation.

Authors:  Mark C Dessing; Jesper Kers; Jeffrey Damman; Gerjan J Navis; Sandrine Florquin; Jaklien C Leemans
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

8.  Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literature.

Authors:  Justine Huart; Jean-Marie Krzesinski; François Jouret
Journal:  Clin Kidney J       Date:  2018-04-03

9.  Toll-Like Receptor Family Polymorphisms Are Associated with Primary Renal Diseases but Not with Renal Outcomes Following Kidney Transplantation.

Authors:  Mark C Dessing; Jesper Kers; Jeffrey Damman; Henri G D Leuvenink; Harry van Goor; Jan-Luuk Hillebrands; Bouke G Hepkema; Harold Snieder; Jacob van den Born; Martin H de Borst; Stephan J L Bakker; Gerjan J Navis; Rutger J Ploeg; Sandrine Florquin; Marc Seelen; Jaklien C Leemans
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

10.  Protective Effect of Luteolin Against Renal Ischemia/Reperfusion Injury via Modulation of Pro-Inflammatory Cytokines, Oxidative Stress and Apoptosis for Possible Benefit in Kidney Transplant.

Authors:  Yan Liu; Baoxin Shi; Yi Li; Hui Zhang
Journal:  Med Sci Monit       Date:  2017-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.